The Bill & Melinda Gates Foundation Committed $400 Million for a TB Vaccine Trial (M72) in Africa and Southeast Asia

The Bill & Melinda Gates Foundation (BMGF) announced in a press release last Wednesday, June 28, the phase III clinical trial of M72, a vaccine for tuberculosis (TB) as part of their “virtuous” effort to develop and use novel biomedical interventions for addressing “global health concerns”. The trials will be conducted on 26,000 participants from […]

The post The Bill & Melinda Gates Foundation Committed $400 Million for a TB Vaccine Trial (M72) in Africa and Southeast Asia appeared first on News Magazine.